| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2023 ( Subtotal = $3,770,028 ) |
| | 2023 | 2023 | HEALTH RESEARCH, INC. | ELM AND CARLTON ST | BUFFALO | NY | 14263-0001 | ERIE | USA | UG1CA233191 | Network Lead Academic Participating Site Grant from the Roswell Park Cancer Institute | 000 | 4 | NIH | 1/10/2023 | $25,000 |
| | 2023 | 2023 | HEALTH RESEARCH, INC. | ELM AND CARLTON ST | BUFFALO | NY | 14263-0001 | ERIE | USA | R01HL150266 | Inhibition of Radiation-Induced Coronary Microvascular Disease | 000 | 3 | NIH | 12/21/2022 | $363,028 |
| | 2023 | 2023 | HEALTH RESEARCH, INC. | ELM AND CARLTON ST | BUFFALO | NY | 14263-0001 | ERIE | USA | R01CA243456 | Radiogenomic Credentialing of Head and Neck Cancer Models | 000 | 3 | NIH | 11/23/2022 | $536,145 |
| | 2023 | 2023 | HEALTH RESEARCH, INC. | ELM AND CARLTON ST | BUFFALO | NY | 14263-0001 | ERIE | USA | R37CA248018 | Leveraging the GTP Biosynthetic Pathway for Anti-Tumor Therapies | 000 | 3 | NIH | 11/21/2022 | $345,221 |
| | 2023 | 2023 | HEALTH RESEARCH, INC. | ELM AND CARLTON ST | BUFFALO | NY | 14263-0001 | ERIE | USA | R01CA250412 | Impact of Circulating Myeloid Cell Clusters on Anti-Tumor Immunity | 000 | 3 | NIH | 12/7/2022 | $624,758 |
| | 2023 | 2023 | HEALTH RESEARCH, INC. | ELM AND CARLTON ST | BUFFALO | NY | 14263-0001 | ERIE | USA | F31CA260942 | Impact of benzodiazepines on the pancreatic tumor microenvironment | 000 | 2 | NIH | 12/28/2022 | $31,317 |
| | 2023 | 2023 | HEALTH RESEARCH, INC. | ELM AND CARLTON ST | BUFFALO | NY | 14263-0001 | ERIE | USA | R01CA225947 | Relationships between parity, breastfeeding and ER- breast cancer in African American women: Elucidating the biologic underpinnings at the molecular and cellular level. | 000 | 5 | NIH | 11/23/2022 | $543,871 |
| | 2023 | 2023 | HEALTH RESEARCH, INC. | ELM AND CARLTON ST | BUFFALO | NY | 14263-0001 | ERIE | USA | R21CA267274 | Development of TLR5 agonist based approaches to boost chemo-immunotherapy by modulating immunosuppressive networks | 000 | 2 | NIH | 11/23/2022 | $176,926 |
| | 2023 | 2023 | HEALTH RESEARCH, INC. | ELM AND CARLTON ST | BUFFALO | NY | 14263-0001 | ERIE | USA | R21CA259719 | A Novel Treatment Strategy for Metastatic Breast Cancer | 000 | 2 | NIH | 11/23/2022 | $176,926 |
| | 2023 | 2023 | HEALTH RESEARCH, INC. | ELM AND CARLTON ST | BUFFALO | NY | 14263-0001 | ERIE | USA | R01ES034250 | STAG2 modulates environmental toxicant exposures and epigenomic heterogeneity | 001 | 2 | NIH | 12/30/2022 | $597,213 |
| | 2023 | 2023 | HEALTH RESEARCH, INC. | ELM AND CARLTON ST | BUFFALO | NY | 14263-0001 | ERIE | USA | R01CA258337 | Behavioral Parenting Skills as a Novel Target for Improving Pediatric Medication Adherence | 000 | 2 | NIH | 12/1/2022 | $581,695 |
| | 2023 | 2022 | HEALTH RESEARCH, INC. | ELM AND CARLTON ST | BUFFALO | NY | 14263-0001 | ERIE | USA | U01CA256801 | Optimizing Dual-Targeted and Dual-Armored CAR T Cells for Small Cell LungCancer | 001 | 2 | NIH | 12/1/2022 | $0 |
| | 2023 | 2022 | HEALTH RESEARCH, INC. | ELM AND CARLTON ST | BUFFALO | NY | 14263-0001 | ERIE | USA | R01DA057228 | Assessing pharmacokinetic and pharmacodynamic variability of ?9-tetrahydrocannabinol delivered from vaping products with and without concurrent use of nicotine | 000 | 1 | NIH | 1/9/2023 | $0 |
| | 2023 | 2022 | HEALTH RESEARCH, INC. | ELM AND CARLTON ST | BUFFALO | NY | 14263-0001 | ERIE | USA | R03CA262845 | Leveraging tissue-specific regulatory maps and network-assisted analysis to identify novel genetic risk loci for esophageal adenocarcinoma | 000 | 1 | NIH | 10/24/2022 | $0 |
| | 2023 | 2022 | HEALTH RESEARCH, INC. | ELM AND CARLTON ST | BUFFALO | NY | 14263-0001 | ERIE | USA | R01ES034250 | STAG2 modulates environmental toxicant exposures and epigenomic heterogeneity | 000 | 1 | NIH | 10/24/2022 | $18,243 |
| | 2023 | 2022 | HEALTH RESEARCH, INC. | ELM AND CARLTON ST | BUFFALO | NY | 14263-0001 | ERIE | USA | R01DK128615 | Genetic susceptibility to Barrett's esophagus: From GWAS to biology | 000 | 1 | NIH | 1/9/2023 | $0 |
| | 2023 | 2022 | HEALTH RESEARCH, INC. | ELM AND CARLTON ST | BUFFALO | NY | 14263-0001 | ERIE | USA | T32CA085183 | Multidisciplinary Approaches to Tumor Immunology | 000 | 20 | NIH | 10/14/2022 | $0 |
| | 2023 | 2021 | HEALTH RESEARCH, INC. | ELM AND CARLTON ST | BUFFALO | NY | 14263-0001 | ERIE | USA | P01CA234212 | Targeting the Chemokine System to Sensitize Tumors to Immunotherapy | 000 | 2 | NIH | 11/16/2022 | $0 |
| | 2023 | 2021 | HEALTH RESEARCH, INC. | ELM AND CARLTON ST | BUFFALO | NY | 14263-0001 | ERIE | USA | P01CA234212 | Targeting the Chemokine System to Sensitize Tumors to Immunotherapy | 001 | 2 | NIH | 12/16/2022 | $0 |
| | 2023 | 2021 | HEALTH RESEARCH, INC. | ELM AND CARLTON ST | BUFFALO | NY | 14263-0001 | ERIE | USA | R01AT010216 | Flaxseed effects on gut microbial metabolism and circulating inflammation-related metabolic profiles in African American and non-Hispanic white women | 001 | 4 | NIH | 12/20/2022 | $0 |
| | 2023 | 2021 | HEALTH RESEARCH, INC. | ELM AND CARLTON ST | BUFFALO | NY | 14263-0001 | ERIE | USA | R01AT010216 | Flaxseed effects on gut microbial metabolism and circulating inflammation-related metabolic profiles in African American and non-Hispanic white women | 000 | 4 | NIH | 10/20/2022 | $0 |
| | 2023 | 2021 | HEALTH RESEARCH, INC. | ELM AND CARLTON ST | BUFFALO | NY | 14263-0001 | ERIE | USA | R01AI140736 | ST6Gal-1 Sialyltransferase in Inflammation | 000 | 4 | NIH | 12/15/2022 | $0 |
| | 2023 | 2021 | HEALTH RESEARCH, INC. | ELM AND CARLTON ST | BUFFALO | NY | 14263-0001 | ERIE | USA | R01CA211912 | Regulation of non-proteolytic ubiquitination in cancer chemoresistance and progression | 000 | 5 | NIH | 1/13/2023 | $0 |
| | 2023 | 2020 | HEALTH RESEARCH, INC. | ELM AND CARLTON ST | BUFFALO | NY | 14263-0001 | ERIE | USA | R21CA253910 | A pragmatic dietary intervention to improve bladder cancer survivorship | 000 | 1 | NIH | 10/14/2022 | $0 |
| | 2023 | 2020 | HEALTH RESEARCH, INC. | ELM AND CARLTON ST | BUFFALO | NY | 14263-0001 | ERIE | USA | R21CA226463 | "Combining radiation with TLR5 agonist based immunotherapy against liver metastases" | 000 | 2 | NIH | 10/24/2022 | $0 |
| | 2023 | 2020 | HEALTH RESEARCH, INC. | ELM AND CARLTON ST | BUFFALO | NY | 14263-0001 | ERIE | USA | F31CA228396 | Regulation of IRF8 in PMN-MDSC Development Within the Bone Marrow Microenvironment | 000 | 3 | NIH | 11/23/2022 | -$26 |
| | 2023 | 2020 | HEALTH RESEARCH, INC. | ELM AND CARLTON ST | BUFFALO | NY | 14263-0001 | ERIE | USA | R01CA193610 | Integrated Image-Guided Dosimetry and Treatment Planning for Photodynamic Therapy | 000 | 5 | NIH | 12/13/2022 | $0 |
| | 2023 | 2020 | HEALTH RESEARCH, INC. | ELM AND CARLTON ST | BUFFALO | NY | 14263-0001 | ERIE | USA | R01CA193610 | Integrated Image-Guided Dosimetry and Treatment Planning for Photodynamic Therapy | 000 | 5 | NIH | 12/13/2022 | $0 |
| | 2023 | 2020 | HEALTH RESEARCH, INC. | ELM AND CARLTON ST | BUFFALO | NY | 14263-0001 | ERIE | USA | U24CA180996 | Cancer Genomics: Integrative and Scalable Solutions in R/Bioconductor | 000 | 8 | NIH | 11/2/2022 | -$250,289 |
|
| Issue Date FY: 2022 ( Subtotal = $38,173,601 ) (Continued on the next page) |
| | 2022 | 2022 | HEALTH RESEARCH, INC. | ELM AND CARLTON ST | BUFFALO | NY | 14263-0001 | ERIE | USA | R21CA267002 | Tumor and immune cell co-evolutionary dynamics as a source of racial disparities in breast cancer | 000 | 1 | NIH | 7/28/2022 | $243,334 |
| | 2022 | 2022 | HEALTH RESEARCH, INC. | ELM AND CARLTON ST | BUFFALO | NY | 14263-0001 | ERIE | USA | F99CA274655 | Impact of Numeracy on Risk Perceptions of Tobacco-Related Diseases | 000 | 1 | NIH | 7/21/2022 | $33,780 |
| | 2022 | 2022 | HEALTH RESEARCH, INC. | ELM AND CARLTON ST | BUFFALO | NY | 14263-0001 | ERIE | USA | R01ES034250 | STAG2 modulates environmental toxicant exposures and epigenomic heterogeneity | 000 | 1 | NIH | 3/18/2022 | $578,970 |
| | 2022 | 2022 | HEALTH RESEARCH, INC. | ELM AND CARLTON ST | BUFFALO | NY | 14263-0001 | ERIE | USA | R21CA259719 | A Novel Treatment Strategy for Metastatic Breast Cancer | 000 | 1 | NIH | 12/14/2021 | $235,901 |
| | 2022 | 2022 | HEALTH RESEARCH, INC. | ELM AND CARLTON ST | BUFFALO | NY | 14263-0001 | ERIE | USA | R01DK128615 | Genetic susceptibility to Barrett's esophagus: From GWAS to biology | 000 | 1 | NIH | 12/20/2021 | $762,225 |
| | 2022 | 2022 | HEALTH RESEARCH, INC. | ELM AND CARLTON ST | BUFFALO | NY | 14263-0001 | ERIE | USA | R21CA267274 | Development of TLR5 agonist based approaches to boost chemo-immunotherapy by modulating immunosuppressive networks | 000 | 1 | NIH | 12/22/2021 | $235,901 |
| | 2022 | 2022 | HEALTH RESEARCH, INC. | ELM AND CARLTON ST | BUFFALO | NY | 14263-0001 | ERIE | USA | R01CA258337 | Behavioral Parenting Skills as a Novel Target for Improving Pediatric Medication Adherence | 000 | 1 | NIH | 12/15/2021 | $665,941 |
| | 2022 | 2022 | HEALTH RESEARCH, INC. | ELM AND CARLTON ST | BUFFALO | NY | 14263-0001 | ERIE | USA | R03CA256122 | Examining the impact of endogenous CD28 signaling on CAR T cells | 000 | 2 | NIH | 11/22/2021 | $84,100 |
| | 2022 | 2022 | HEALTH RESEARCH, INC. | ELM AND CARLTON ST | BUFFALO | NY | 14263-0001 | ERIE | USA | R01EB029398 | Synchronized brain dynamics and eye movement trajectory for objective evaluation of robot-assisted surgical skills | 001 | 3 | NIH | 6/24/2022 | $359,997 |
| | 2022 | 2022 | HEALTH RESEARCH, INC. | ELM AND CARLTON ST | BUFFALO | NY | 14263-0001 | ERIE | USA | R01EB029398 | Synchronized brain dynamics and eye movement trajectory for objective evaluation of robot-assisted surgical skills | 002 | 3 | NIH | 6/30/2022 | $39,308 |
| | 2022 | 2022 | HEALTH RESEARCH, INC. | ELM AND CARLTON ST | BUFFALO | NY | 14263-0001 | ERIE | USA | R01EB029398 | Synchronized brain dynamics and eye movement trajectory for objective evaluation of robot-assisted surgical skills | 000 | 3 | NIH | 2/8/2022 | $353,767 |
| | 2022 | 2022 | HEALTH RESEARCH, INC. | ELM AND CARLTON ST | BUFFALO | NY | 14263-0001 | ERIE | USA | R01CA255515 | Metformin for chemoprevention of lung cancer in obese subjects at high risk | 001 | 2 | NIH | 8/31/2022 | $69,151 |
| | 2022 | 2022 | HEALTH RESEARCH, INC. | ELM AND CARLTON ST | BUFFALO | NY | 14263-0001 | ERIE | USA | R01CA255515 | Metformin for chemoprevention of lung cancer in obese subjects at high risk | 000 | 2 | NIH | 7/25/2022 | $584,429 |
| | 2022 | 2022 | HEALTH RESEARCH, INC. | ELM AND CARLTON ST | BUFFALO | NY | 14263-0001 | ERIE | USA | R01CA262899 | Multi-ethnic high-throughput study to identify novel non-HLA genetic contributors to mortality after blood and marrow transplantation | 000 | 2 | NIH | 7/25/2022 | $463,641 |
| | 2022 | 2022 | HEALTH RESEARCH, INC. | ELM AND CARLTON ST | BUFFALO | NY | 14263-0001 | ERIE | USA | R21CA256321 | Development of a Novel Immunotherapy Platform for Triple-Negative Breast Cancer | 000 | 2 | NIH | 6/22/2022 | $192,653 |
| | 2022 | 2022 | HEALTH RESEARCH, INC. | ELM AND CARLTON ST | BUFFALO | NY | 14263-0001 | ERIE | USA | R21DA053614 | Assessing the impacts of the four 2019/2020 US federal-level tobacco control actions: flavors, youth marketing, youth access, and Tobacco 21 | 000 | 2 | NIH | 4/13/2022 | $180,439 |
| | 2022 | 2022 | HEALTH RESEARCH, INC. | ELM AND CARLTON ST | BUFFALO | NY | 14263-0001 | ERIE | USA | U01CA256801 | Optimizing Dual-Targeted and Dual-Armored CAR T Cells for Small Cell LungCancer | 001 | 2 | NIH | 6/1/2022 | $585,015 |
| | 2022 | 2022 | HEALTH RESEARCH, INC. | ELM AND CARLTON ST | BUFFALO | NY | 14263-0001 | ERIE | USA | U01CA256801 | Optimizing Dual-Targeted and Dual-Armored CAR T Cells for Small Cell LungCancer | 003 | 2 | NIH | 6/10/2022 | $423,072 |
| | 2022 | 2022 | HEALTH RESEARCH, INC. | ELM AND CARLTON ST | BUFFALO | NY | 14263-0001 | ERIE | USA | R03CA246001 | Novel 7SK non-coding RNA fusions in soft tissue sarcomas to tumorigenesis | 000 | 2 | NIH | 3/1/2022 | $84,100 |
|
